Before joining KLOwen, Paige refined her marketing craft with companies such as Candid, Align Technology, Lenovo, and Verizon
DiMarchi continues to advance innovation in the treatment of metabolic diseases through research and translational science
In a D-Asp oxidase knockout mouse model, treatment with D-Asp significantly alleviated phencyclidine-induced cortico-limbic thalamic dysfunction and reduced neuronal prepulse deficits induced by psychotropic drugs (amphetamine and MK-801)
These medications are proven excellent for weight reduction and weight control, and since obesity is such a huge problem, especially in diabetic patients, these medications not only treat hyperglycemia, but also obesity, which makes them a great choice when treating a diabetic patient with obesity, she explained.